mRNA CDMO

mRNA Manufacturing Services

Comprehensive and fully integrated platform for mRNA vaccine and therapy, accelerating the development of life-saving treatments.

One-stop mRNA CDMO Service

  • Plasmid DNA (pDNA) production: Creating the DNA template used to manufacture the mRNA.
  • mRNA design and optimization: Designing the mRNA sequence for efficient protein production and incorporating modifications for stability and delivery.
  • mRNA manufacturing: Large-scale production of the mRNA molecule under GMP (Good Manufacturing Practice) regulations.
  • Analytical testing and quality control: Rigorous testing to ensure the mRNA meets purity, potency, and safety standards.
  • Formulation and fill-finish: Formulation of the mRNA into a stable and injectable product, followed by filling vials or syringes.
    • Submit Request

    State-of-the-art Facility

    Our mRNA facility is equipped with advanced technology and processes to ensure efficient, high-quality production of mRNA therapeutics and vaccines. It consists of more than 30,000 square feet of laboratory and GMP manufacturing. It supports the production of non-GMP products for formulation development and toxicology studies, as well as GMP products for early and late-stage clinical trials. Operations commenced in 2021. 

    Complete mRNA Raw Material Portfolio

    We manufacture a comprehensive range of raw materials in-house, including nucleosides, nucleotides, modified nucleotides, enzymes, cap analogues, and lipids, allowing researchers and manufacturers to focus on their mRNA development efforts without having to worry about sourcing quality materials. 

    State-of-the-art Facility

    Our mRNA facility is equipped with advanced technology and processes to ensure efficient, high-quality production of mRNA therapeutics and vaccines. It consists of more than 30,000 square feet of laboratory and GMP manufacturing. It supports the production of non-GMP products for formulation development and toxicology studies, as well as GMP products for early and late-stage clinical trials. Operations commenced in 2021. 

    Back to top

    My Wishlist